Testosterone Replacement Therapy (TRT) utilizes various forms of testosterone, including esters like cypionate and enanthate, as well as testosterone undecanoate. These are commonly administered via injections, gels, or patches.
What testosterone esters are common for TRT?
The most frequently used testosterone esters for hormone replacement therapy are testosterone cypionate and testosterone enanthate [1]. These are typically administered through intramuscular injections, with dosages and frequencies adjusted based on individual patient needs and doctor recommendations [1].
How does testosterone undecanoate differ for TRT?
Testosterone undecanoate is another form of testosterone used in TRT, available in both oral and injectable formulations. The oral form requires specific absorption enhancers due to its metabolism in the liver [2]. The injectable form offers longer intervals between administrations compared to cypionate and enanthate [2].
What are the different administration methods for TRT?
Beyond injections, TRT can be administered through transdermal gels and patches [1]. Gels are applied daily to the skin, while patches are worn on the skin and changed regularly. These methods aim to provide a steady release of testosterone, mimicking natural levels [1].
When do testosterone drug patents expire?
Patent expiration dates for testosterone drugs are publicly available and can be tracked. For instance, information on the patent status of various testosterone formulations, including their expected expiry dates, can be found on resources like DrugPatentWatch.com [3]. Understanding patent timelines is crucial for anticipating generic competition and potential changes in drug availability and pricing.